Form 4 Tracker
Matthew B. Klein

Director; Director, CHIEF EXECUTIVE OFFICER · 6 filings · Latest: May 21, 2026

ClearPoint Neuro, Inc.
PTC THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CLPT
Matthew B. KleinDirectorMay 21, 2026
Sale
$11.5916,000$185.4K46,935
CLPT
Matthew B. KleinDirectorMay 19, 2026
Option Exercise
12,41762,935
CLPT
MATTHEW B KLEINMay 21, 2026
Proposed Sale
$11.5916,000$185.4K
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERMay 14, 2026
Sale
$72.9512,572$917.2K393,998
PTCT
Klein Matthew B.May 14, 2026
Proposed Sale
$72.462,572$186.4K
PTCT
Klein Matthew B.May 14, 2026
Proposed Sale
$73.0810,000$730.8K
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERApr 21, 2026
Sale
$70.912,850$202.1K394,070
PTCT
Klein Matthew B.Apr 21, 2026
Proposed Sale
$70.942,850$202.2K
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERMar 12, 2026
Sale
$64.082,662$170.6K396,920
PTCT
Klein Matthew B.Mar 12, 2026
Proposed Sale
$64.082,662$170.6K
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERFeb 18, 2026
Sale
$69.367,371$511.3K387,082
PTCT
Klein Matthew B.Feb 18, 2026
Proposed Sale
$69.367,371$511.2K
PTCT
Klein Matthew B.Jan 8, 2026
Proposed Sale
$76.452,514$192.2K
PTCT
Klein Matthew B.Jan 7, 2026
Proposed Sale
$77.483,016$233.7K
PTCT
Klein Matthew B.Jan 6, 2026
Proposed Sale
$76.955,149$396.2K
PTCT
Klein Matthew B.Dec 30, 2025
Proposed Sale
$76.648,089$619.9K
PTCT
Klein Matthew B.Dec 2, 2025
Proposed Sale
$79.073,428$271.1K
PTCT
Klein Matthew B.Aug 5, 2025
Proposed Sale
$51.7410,739$555.7K
PTCT
Klein Matthew B.Apr 22, 2025
Proposed Sale
$48.742,804$136.7K
PTCT
Klein Matthew B.Feb 20, 2025
Proposed Sale
$50.123,895$195.2K

Page 1 of 2

Next →